FDA approves LEQEMBI IQLIK for maintenance dosing in early Alzheimer’s disease
1st September 2025 Uncategorised 0New subcutaneous autoinjector offers at-home treatment option for patients More: FDA approves LEQEMBI IQLIK for maintenance dosing in early Alzheimer’s disease Source: News
read more

